April 22, 2026: Removed from Category 2 On April 15, 2026, the FDA published a 503A category revision removing 12 peptides from Category 2 effective seven calendar days later (April 22)
Implementing practical strategies helps optimize treatment outcomes while minimizing complications
It is a synthetic peptide that mimics the effects of GLP-1, a hormone that regulates appetite and fat metabolism
Product Review SAMe (S-adenosyl-methionine) Supplements Review Choose the Best SAMe Supplement and Save Money Recalls & Warnings January 21, 2017 Seller of "Cancer Kits," Alpha Lipoic Acid Supplements and More Warned for Drug Claims On December 22, 2016, the FDA issued a warning letter to Northern Health Products, Inc
Ongoing monitoring is important to evaluate side effects and overall health